A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

T. L. Stevens, John C Jr. Burnett, M. Kinoshita, Y. Matsuda, Margaret May Redfield

Research output: Contribution to journalArticle

101 Citations (Scopus)

Abstract

Asymptomatic or early left ventricular dysfunction in humans is characterized by increases in circulating atrial natriuretic peptide (ANP) without activation of the renin-angiotensin-aldosterone system (RAAS). We previously reported a canine model of early left ventricular dysfunction (ELVD) produced by rapid ventricular pacing and characterized by an identical neurohumoral profile and maintenance of the natriuretic response to volume expansion (VE). To test the hypothesis that elevated endogenous ANP suppresses the RAAS and maintains sodium excretion in ELVD, we assessed the effects of antagonism of ANP on cardiorenal and neurohumoral function in ELVD. Chronic ANP suppression was produced by bilateral atrial appendectomies before the production of ELVD by rapid ventricular pacing (ELVD-APPX, n = 5). This group was compared with a separate group with ELVD and intact atrial appendages (ELVD-INTACT, n = 8). ELVD-APPX was characterized by lower circulating ANP (50±11 vs. 158±37 pg/ml, P < 0.05), activation of plasma renin activity (PRA) (9.4±2.4 vs. 0.6±0.4 ng/ml per h, P < 0.05) and aldosterone (36.4±12.5 vs. 2.5±0.0 ng/dl, P < 0.05) when compared to ELVD- INTACT. In comparison to the ELVD-INTACT group, sodium excretion was decreased before and during VE in the ELVD-APPX group. Acute ANP antagonism was produced by administration of the particulate guanylate cyclase coupled natriuretic peptide receptor antagonist, HS-142-1, to seven conscious dogs with ELVD and intact atrial appendages (ELVD-INTACT). HS-142-1 decreased plasma concentrations and renal generation of the ANP second messenger, cGMP, and was associated with activation of PRA and sodium retention with enhanced tubular sodium reabsorption. These data support a significant role for elevated endogenous ANP in the maintenance of sodium excretion and regulation of the RAAS in experimental ELVD.

Original languageEnglish (US)
Pages (from-to)1101-1108
Number of pages8
JournalJournal of Clinical Investigation
Volume95
Issue number3
StatePublished - 1995

Fingerprint

Left Ventricular Dysfunction
Atrial Natriuretic Factor
Canidae
Sodium
Renin-Angiotensin System
Atrial Appendage
Renin
Maintenance
Natriuretic Peptides
Appendectomy
Peptide Receptors
Guanylate Cyclase
Second Messenger Systems
Aldosterone

ASJC Scopus subject areas

  • Medicine(all)

Cite this

A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction. / Stevens, T. L.; Burnett, John C Jr.; Kinoshita, M.; Matsuda, Y.; Redfield, Margaret May.

In: Journal of Clinical Investigation, Vol. 95, No. 3, 1995, p. 1101-1108.

Research output: Contribution to journalArticle

@article{a780fb30866644b895f27b810b4a1cd5,
title = "A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction",
abstract = "Asymptomatic or early left ventricular dysfunction in humans is characterized by increases in circulating atrial natriuretic peptide (ANP) without activation of the renin-angiotensin-aldosterone system (RAAS). We previously reported a canine model of early left ventricular dysfunction (ELVD) produced by rapid ventricular pacing and characterized by an identical neurohumoral profile and maintenance of the natriuretic response to volume expansion (VE). To test the hypothesis that elevated endogenous ANP suppresses the RAAS and maintains sodium excretion in ELVD, we assessed the effects of antagonism of ANP on cardiorenal and neurohumoral function in ELVD. Chronic ANP suppression was produced by bilateral atrial appendectomies before the production of ELVD by rapid ventricular pacing (ELVD-APPX, n = 5). This group was compared with a separate group with ELVD and intact atrial appendages (ELVD-INTACT, n = 8). ELVD-APPX was characterized by lower circulating ANP (50±11 vs. 158±37 pg/ml, P < 0.05), activation of plasma renin activity (PRA) (9.4±2.4 vs. 0.6±0.4 ng/ml per h, P < 0.05) and aldosterone (36.4±12.5 vs. 2.5±0.0 ng/dl, P < 0.05) when compared to ELVD- INTACT. In comparison to the ELVD-INTACT group, sodium excretion was decreased before and during VE in the ELVD-APPX group. Acute ANP antagonism was produced by administration of the particulate guanylate cyclase coupled natriuretic peptide receptor antagonist, HS-142-1, to seven conscious dogs with ELVD and intact atrial appendages (ELVD-INTACT). HS-142-1 decreased plasma concentrations and renal generation of the ANP second messenger, cGMP, and was associated with activation of PRA and sodium retention with enhanced tubular sodium reabsorption. These data support a significant role for elevated endogenous ANP in the maintenance of sodium excretion and regulation of the RAAS in experimental ELVD.",
author = "Stevens, {T. L.} and Burnett, {John C Jr.} and M. Kinoshita and Y. Matsuda and Redfield, {Margaret May}",
year = "1995",
language = "English (US)",
volume = "95",
pages = "1101--1108",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "3",

}

TY - JOUR

T1 - A functional role for endogenous atrial natriuretic peptide in a canine model of early left ventricular dysfunction

AU - Stevens, T. L.

AU - Burnett, John C Jr.

AU - Kinoshita, M.

AU - Matsuda, Y.

AU - Redfield, Margaret May

PY - 1995

Y1 - 1995

N2 - Asymptomatic or early left ventricular dysfunction in humans is characterized by increases in circulating atrial natriuretic peptide (ANP) without activation of the renin-angiotensin-aldosterone system (RAAS). We previously reported a canine model of early left ventricular dysfunction (ELVD) produced by rapid ventricular pacing and characterized by an identical neurohumoral profile and maintenance of the natriuretic response to volume expansion (VE). To test the hypothesis that elevated endogenous ANP suppresses the RAAS and maintains sodium excretion in ELVD, we assessed the effects of antagonism of ANP on cardiorenal and neurohumoral function in ELVD. Chronic ANP suppression was produced by bilateral atrial appendectomies before the production of ELVD by rapid ventricular pacing (ELVD-APPX, n = 5). This group was compared with a separate group with ELVD and intact atrial appendages (ELVD-INTACT, n = 8). ELVD-APPX was characterized by lower circulating ANP (50±11 vs. 158±37 pg/ml, P < 0.05), activation of plasma renin activity (PRA) (9.4±2.4 vs. 0.6±0.4 ng/ml per h, P < 0.05) and aldosterone (36.4±12.5 vs. 2.5±0.0 ng/dl, P < 0.05) when compared to ELVD- INTACT. In comparison to the ELVD-INTACT group, sodium excretion was decreased before and during VE in the ELVD-APPX group. Acute ANP antagonism was produced by administration of the particulate guanylate cyclase coupled natriuretic peptide receptor antagonist, HS-142-1, to seven conscious dogs with ELVD and intact atrial appendages (ELVD-INTACT). HS-142-1 decreased plasma concentrations and renal generation of the ANP second messenger, cGMP, and was associated with activation of PRA and sodium retention with enhanced tubular sodium reabsorption. These data support a significant role for elevated endogenous ANP in the maintenance of sodium excretion and regulation of the RAAS in experimental ELVD.

AB - Asymptomatic or early left ventricular dysfunction in humans is characterized by increases in circulating atrial natriuretic peptide (ANP) without activation of the renin-angiotensin-aldosterone system (RAAS). We previously reported a canine model of early left ventricular dysfunction (ELVD) produced by rapid ventricular pacing and characterized by an identical neurohumoral profile and maintenance of the natriuretic response to volume expansion (VE). To test the hypothesis that elevated endogenous ANP suppresses the RAAS and maintains sodium excretion in ELVD, we assessed the effects of antagonism of ANP on cardiorenal and neurohumoral function in ELVD. Chronic ANP suppression was produced by bilateral atrial appendectomies before the production of ELVD by rapid ventricular pacing (ELVD-APPX, n = 5). This group was compared with a separate group with ELVD and intact atrial appendages (ELVD-INTACT, n = 8). ELVD-APPX was characterized by lower circulating ANP (50±11 vs. 158±37 pg/ml, P < 0.05), activation of plasma renin activity (PRA) (9.4±2.4 vs. 0.6±0.4 ng/ml per h, P < 0.05) and aldosterone (36.4±12.5 vs. 2.5±0.0 ng/dl, P < 0.05) when compared to ELVD- INTACT. In comparison to the ELVD-INTACT group, sodium excretion was decreased before and during VE in the ELVD-APPX group. Acute ANP antagonism was produced by administration of the particulate guanylate cyclase coupled natriuretic peptide receptor antagonist, HS-142-1, to seven conscious dogs with ELVD and intact atrial appendages (ELVD-INTACT). HS-142-1 decreased plasma concentrations and renal generation of the ANP second messenger, cGMP, and was associated with activation of PRA and sodium retention with enhanced tubular sodium reabsorption. These data support a significant role for elevated endogenous ANP in the maintenance of sodium excretion and regulation of the RAAS in experimental ELVD.

UR - http://www.scopus.com/inward/record.url?scp=0028966468&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028966468&partnerID=8YFLogxK

M3 - Article

C2 - 7883958

AN - SCOPUS:0028966468

VL - 95

SP - 1101

EP - 1108

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 3

ER -